A Review of Antithrombotic Agents in Dermatologic Surgery and Context for a Practical Approach, With Cardiology and Pharmacologic Input

Elizabeth Rao, Wyatt Andrasik, Basia M. Michalski, Khaldoun G. Tarakji, Michael A. Militello, Jennifer L. Lucas

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Dermatologic surgeons are encountering more patients on antithrombotic agents. There are no established consensus guidelines for managing antithrombotic agents in the perioperative period. We provide an updated overview of antithrombotic agents in dermatologic surgery and management of such agents in the perioperative period with additional unique perspectives from cardiology and pharmacy. A literature search of PubMed and Google Scholar was performed to review the English-language medical literature. The landscape of antithrombotic therapy is changing with a notable rise in the use of direct oral anticoagulants (DOACs.) While no consensus guidelines exist, most studies recommend continuing antithromboticDo therapy NotinCopy the perioperative period with appropriate lab monitoring, when applicable. However, recent data suggest it is safe to hold Penalties DOACs in Apply the perioperative period. As antithrombotic therapy evolves, the dermatologic surgeon needs to remain current with the most recent available data. Where data are limited, a multidisciplinary approach to managing these agents in the perioperative period is essential.

Original languageEnglish
Pages (from-to)496-501
Number of pages6
JournalJournal of Drugs in Dermatology
Volume22
Issue number5
DOIs
StatePublished - May 2023

Fingerprint

Dive into the research topics of 'A Review of Antithrombotic Agents in Dermatologic Surgery and Context for a Practical Approach, With Cardiology and Pharmacologic Input'. Together they form a unique fingerprint.

Cite this